Overview of Patent Ductus Arteriosus, Diagnosis, Treatment Approaches

Abstract: In this review, we intended to overview the diagnosis and treatment options of Patent ductus arteriosus (PDA) by summarizing evidence for PDA diagnosis methods and the available therapeutic interventions for this heart congenital disease. Electronic Databases (MEDLINE, PubMed, and Emabse) were used to conduct a comprehensive review on Patent ductus arteriosus (PDA) in general and specifically the diagnostic approaches and treatment options. Restriction to English language published study up to December, 2016 was applied. Furthermore, references list of identified studies was searched for more relevant articles. Typical medical diagnosis among exceptionally premature infants, specifically in those with lung disease. Treatments are frequently utilized to close the PDA. Despite nearly 3 years of research, the question of whether the advantages of treatments to prevent ductal patency or promote closure surpass the threats of these treatments remains unanswered. The authors seldom utilize treatments created to close the PDA. Spontaneous closure of the patent ductus arteriosus (PDA) prevails. Therapy is normally sensible if considerable breathing distress or impaired systemic oxygen shipment is present. Intravenous (IV) indomethacin (or the more recent preparation of IV ibuprofen) is frequently efficient in closing a patent ductus arteriosus (PDA) if it is administered in the first 10-14 days of life. Author: Ahmad Jaber Aseeri, Abdulrahman mohammed asiri, Suliman Abdullah assri, Turki Ali Abdullah AlElyani, Mohammed Omar Mohammed Alsayed, Ahmed Omar Al Khudhayr, Faiz Jaber Hassan Sahari, Abdullah Abdu Alasmari Title: Overview of Patent Ductus Arteriosus, Diagnosis, Treatment Approaches International Journal of Healthcare Sciences ISSN 2348-5728 (Online) Research Publish Journals

Citation